Return On Assets of aTYR PHARMA INC from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
aTYR PHARMA INC quarterly and annual Return On Assets in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • aTYR PHARMA INC Return On Assets for the quarter ending 30 Sep 2025 was -75%, a 26% decline year-over-year.
  • aTYR PHARMA INC annual Return On Assets for 2024 was -63%, a 61% decline from 2023.
  • aTYR PHARMA INC annual Return On Assets for 2023 was -39%, a 15% increase from 2022.
  • aTYR PHARMA INC annual Return On Assets for 2022 was -46%, a 18% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

aTYR PHARMA INC Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -75% -16% -26% 01 Jul 2025 30 Sep 2025
Q2 2025 -69% -19% -38% 01 Apr 2025 30 Jun 2025
Q1 2025 -65% -21% -48% 01 Jan 2025 31 Mar 2025
Q4 2024 -63% -24% -61% 01 Oct 2024 31 Dec 2024
Q3 2024 -59% -24% -68% 01 Jul 2024 30 Sep 2024
Q2 2024 -50% -11% -28% 01 Apr 2024 30 Jun 2024
Q1 2024 -44% -1.4% -3.2% 01 Jan 2024 31 Mar 2024
Q4 2023 -39% +7.1% +15% 01 Oct 2023 31 Dec 2023
Q3 2023 -35% +9.8% +22% 01 Jul 2023 30 Sep 2023
Q2 2023 -39% -2% -5.4% 01 Apr 2023 30 Jun 2023
Q1 2023 -43% -3.1% -7.8% 01 Jan 2023 31 Mar 2023
Q4 2022 -46% -6.9% -18% 01 Oct 2022 31 Dec 2022
Q3 2022 -45% +0.21% +0.46% 01 Jul 2022 30 Sep 2022
Q2 2022 -37% +26% +41% 01 Apr 2022 30 Jun 2022
Q1 2022 -39% +15% +28% 01 Jan 2022 31 Mar 2022
Q4 2021 -39% -3.7% -10% 01 Oct 2021 31 Dec 2021
Q3 2021 -45% -6.8% -18% 01 Jul 2021 30 Sep 2021
Q2 2021 -63% -27% -76% 01 Apr 2021 30 Jun 2021
Q1 2021 -55% -21% -60% 01 Jan 2021 31 Mar 2021
Q4 2020 -36% +17% +33% 01 Oct 2020 31 Dec 2020
Q3 2020 -38% +11% +22% 01 Jul 2020 30 Sep 2020
Q2 2020 -36% +12% +26% 01 Apr 2020 30 Jun 2020
Q1 2020 -34% +18% +34% 01 Jan 2020 31 Mar 2020
Q4 2019 -53% +0.38% +0.71% 01 Oct 2019 31 Dec 2019
Q3 2019 -49% +4.5% +8.4% 01 Jul 2019 30 Sep 2019
Q2 2019 -48% +4.8% +9% 01 Apr 2019 30 Jun 2019
Q1 2019 -52% +4.2% +7.5% 01 Jan 2019 31 Mar 2019
Q4 2018 -53% +8.8% +14% 01 Oct 2018 31 Dec 2018
Q3 2018 -54% +12% +18% 01 Jul 2018 30 Sep 2018
Q2 2018 -53% +18% +25% 01 Apr 2018 30 Jun 2018
Q1 2018 -56% +10% +15% 01 Jan 2018 31 Mar 2018
Q4 2017 -62% -1.4% -2.3% 01 Oct 2017 31 Dec 2017
Q3 2017 -65% -7.9% -14% 01 Jul 2017 30 Sep 2017
Q2 2017 -71% -22% -45% 01 Apr 2017 30 Jun 2017
Q1 2017 -66% -26% -63% 01 Jan 2017 31 Mar 2017
Q4 2016 -61% -21% -53% 01 Oct 2016 31 Dec 2016
Q3 2016 -57% -17% -43% 01 Jul 2016 30 Sep 2016
Q2 2016 -49% 01 Apr 2016 30 Jun 2016
Q1 2016 -41% 01 Jan 2016 31 Mar 2016
Q4 2015 -40% 01 Oct 2015 31 Dec 2015
Q3 2015 -40% 01 Jul 2015 30 Sep 2015

aTYR PHARMA INC Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -63% -24% -61% 01 Jan 2024 31 Dec 2024
2023 -39% +7.1% +15% 01 Jan 2023 31 Dec 2023
2022 -46% -6.9% -18% 01 Jan 2022 31 Dec 2022
2021 -39% -3.7% -10% 01 Jan 2021 31 Dec 2021
2020 -36% +0.75% +2.1% 01 Jan 2020 31 Dec 2020
2019 -36% +17% +32% 01 Jan 2019 31 Dec 2019
2018 -53% +8.8% +14% 01 Jan 2018 31 Dec 2018
2017 -62% -1.4% -2.3% 01 Jan 2017 31 Dec 2017
2016 -61% -21% -53% 01 Jan 2016 31 Dec 2016
2015 -40% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.